OHSU to participate in clinical trial for potentially 'life-transforming' drug
Oregon Health& Science University is part of a clinical trial for a drug approved this week for a rare and serious genetic disorder called phenylketonuria, or PKU.
The Food and Drug Administration approved Palynziq, a daily enzyme injection for adults with PKU.
The disease affects about 1 in 10,000 to 15,000 people in the U.S. All newborns are screened for the disease, among others, using a “heel stick” blood draw within 24 to 48 hours after birth.
Pat ients are unable to break down an amino…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Elizabeth Hayes Source Type: news
More News: Biotechnology | Clinical Trials | Food and Drug Administration (FDA) | Genetics | Health Management | Phenylketonuria | Science